CPHI vs GILD · rev $4.1M vs P/E 18, rev $29.44B
China Pharma Holdings Inc (CPHI) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CPHI currently screens at market cap $29.0M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CPHI and GILD stock pages for the full models.
Not investment advice.